CLC bio Expands Bioinformatics Consulting Organization in North America
News Feb 02, 2010
CLC bio announces the expansion of our North American consulting organization. The organization, based in Washington, D.C., will function as an integrated part of CLC bio’s global consulting team.
Dr. Saul A. Kravitz, formerly Director of Bioinformatics Software at the J. Craig Venter Institute has joined CLC bio and will lead the North American consulting organization.
"We have experienced a huge increase in the demand for our consulting services in North America. We're involved in a number of customer engagements, ranging from customizing and integrating our solutions with existing IT systems and hardware, to delivering complete analysis results from raw Next Generation Sequencing data", says Director of Consulting Services at CLC bio, Dr. Jannick D. Bendtsen.
Dr. Bendtsen continues, "With the expansion of our North American consulting organization under Saul Kravitz’s experienced leadership, we will enhance our ability to meet the increased demand for consulting and improve our ability to provide Enterprise solutions for our existing and new clients."
Director of North American Consulting Services, Dr. Saul A. Kravitz, adds, "CLC bio has been on my radar for the past couple of years, but their ability to deliver high-throughput sequencing data analysis to scientists really grabbed my attention. I'm excited to join the premier solution provider in the NGS data analysis space and look forward to using my experience and extensive network within bioinformatics to grow our North American organization."
Prior to joining CLC bio, Dr. Saul A. Kravitz served in leadership positions at the J. Craig Venter Institute. He joined JCVI during its startup in 2002, and his team developed the award-winning LIMS supporting JCVI’s DNA sequence facility. In addition, he was responsible for development and operation of JCVI’s high-throughput analysis pipelines for assembly, polymorphism detection, and annotation.
Previously at Celera Genomics, he built and managed the team that developed novel algorithms and software infrastructure supporting high-throughput protein identification and quantitation from mass spectrometry data, and made key contributions to the development of Celera's Whole Genome Shotgun Assembler.
Dr. Kravitz earned MSc and PhD degrees in Electrical and Computer Engineering at Carnegie Mellon University, and a BA in Physics from The Johns Hopkins University.
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.
The architecture of each person’s brain is unique, and differences may influence how quickly people can complete various cognitive tasks.o learn more, scientists are developing a new tool — computational models of the brain — to simulate how the structure of the brain may impact brain activity and, ultimately, human behavior.READ MORE
8th Edition of International Conference and Exhibition on Separation Techniques
Jul 29 - Jul 30, 2019
International Women Health and Breast Cancer Conference
Jul 03 - Jul 05, 2019